Mcdonald Partners LLC Gilead Sciences, Inc. Transaction History

Mcdonald Partners LLC

$390 Million
Q3 2024

A detailed history of Mcdonald Partners LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mcdonald Partners LLC holds 32,397 shares of GILD stock, worth $2.98 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

32,397

Previous 21,717 49.18%

Holding current value

$2.98 Million

Previous $1.49 Million 82.21%

% of portfolio

0.7%

Previous 0.41%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$66.59 - $83.99 $711,181 - $897,013	10,680 Added 49.18%	32,397 $2.72 Million
Q2 2024 Jul 17, 2024	SELL	$63.15 - $72.88 $192,291 - $221,919	-3,045 Reduced 12.3%	21,717 $1.49 Million
Q1 2024 Apr 15, 2024	SELL	$71.58 - $87.29 $362,481 - $442,036	-5,064 Reduced 16.98%	24,762 $1.81 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $528,789 - $599,660	-7,217 Reduced 19.48%	29,826 $2.42 Million
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $169,174 - $184,572	2,288 Added 6.58%	37,043 $2.78 Million
Q2 2023 Jul 17, 2023	BUY	$76.01 - $86.7 $19,230 - $21,935	253 Added 0.73%	34,755 $2.68 Million
Q1 2023 Apr 19, 2023	SELL	$77.31 - $88.08 $47,159 - $53,728	-610 Reduced 1.74%	34,502 $2.86 Million
Q4 2022 Jan 18, 2023	SELL	$62.32 - $89.47 $58,206 - $83,564	-934 Reduced 2.59%	35,112 $0
Q3 2022 Oct 21, 2022	SELL	$59.54 - $68.01 $755,800 - $863,318	-12,694 Reduced 26.04%	36,046 $2.22 Million
Q2 2022 Jul 25, 2022	BUY	$57.72 - $65.01 $188,744 - $212,582	3,270 Added 7.19%	48,740 $3.01 Million
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $2.63 Million - $3.29 Million	45,393 Added 58951.95%	45,470 $2.7 Million
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $2.82 Million - $3.2 Million	-43,487 Reduced 99.82%	77 $5,000
Q3 2021 Nov 24, 2021	SELL	$67.69 - $73.03 $227,979 - $245,965	-3,368 Reduced 7.18%	43,564 $3.04 Million
Q3 2021 Oct 28, 2021	BUY	$67.69 - $73.03 $223,309 - $240,925	3,299 Added 7.56%	46,932 $3.28 Million
Q2 2021 Nov 24, 2021	SELL	$63.47 - $69.35 $221,002 - $241,476	-3,482 Reduced 7.39%	43,633 $3.01 Million
Q2 2021 Jul 23, 2021	BUY	$63.47 - $69.35 $537,400 - $587,186	8,467 Added 21.91%	47,115 $3.24 Million
Q1 2021 Nov 24, 2021	SELL	$60.0 - $68.46 $214,860 - $245,155	-3,581 Reduced 8.48%	38,648 $2.5 Million
Q1 2021 Apr 15, 2021	BUY	$60.0 - $68.46 $519,600 - $592,863	8,660 Added 25.8%	42,229 $2.73 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1.9 Million - $2.17 Million	33,569 New	33,569 $1.96 Million

Others Institutions Holding GILD

# of Institutions

1,917

Shares Held

995M

Call Options Held

10.1M

Put Options Held

9.46M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcdonald Partners LLC with notifications on news.

Account

Mcdonald Partners LLC Gilead Sciences, Inc. Transaction History